Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Stemmer

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancers|October 21, 2020
Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-AnalysisAmos Stemmer, Inbal Shafran, Salomon M Stemmer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2022
Real-world evidence for immunotherapy in the first line setting in small cell lung cancerShira Sagie, Nitzan Maixner, Amos Stemmer, et al.
The Israel Medical Association Journal : IMAJ|October 28, 2025
Evaluating Outcomes of FLOT protocol in Elderly Patients with Locally Advanced Gastric AdenocarcinomaBen Ramon, Amos Stemmer, Keren Levanon, et al.
Journal of Digital Imaging|March 17, 2022
Improving Cardiovascular Disease Prediction Using Automated Coronary Artery Calcium Scoring from Existing Chest CTsNoam Barda, Noa Dagan, Amos Stemmer, et al.
Journal of Molecular Neuroscience : MN|February 20, 2019
Current and Potential Approaches for Defining Disease Signatures: a Systematic ReviewAmos Stemmer, Tal Galili, Tal Kozlovski, et al.
Plos One|August 4, 2020
Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST)Amos Stemmer, Ran Shadmi, Orna Bregman-Amitai, et al.
Cancers|July 2, 2021
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung CancerAmir Onn, Teodor Gottfried, Amos Stemmer, et al.
Journal of Neuro-Oncology|January 12, 2022
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort studyAmir Massarweh, Roi Tschernichovsky, Amos Stemmer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patientsOfer Margalit, Amos Stemmer, William J Chapin, et al.
Journal of Clinical Medicine|May 14, 2022
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 YearsErez Bar-Haim, Noa Eliakim-Raz, Amos Stemmer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|October 21, 2020
Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-AnalysisAmos Stemmer, Inbal Shafran, Salomon M Stemmer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2022
Real-world evidence for immunotherapy in the first line setting in small cell lung cancerShira Sagie, Nitzan Maixner, Amos Stemmer, et al.
The Israel Medical Association Journal : IMAJ|October 28, 2025
Evaluating Outcomes of FLOT protocol in Elderly Patients with Locally Advanced Gastric AdenocarcinomaBen Ramon, Amos Stemmer, Keren Levanon, et al.
Journal of Digital Imaging|March 17, 2022
Improving Cardiovascular Disease Prediction Using Automated Coronary Artery Calcium Scoring from Existing Chest CTsNoam Barda, Noa Dagan, Amos Stemmer, et al.
Journal of Molecular Neuroscience : MN|February 20, 2019
Current and Potential Approaches for Defining Disease Signatures: a Systematic ReviewAmos Stemmer, Tal Galili, Tal Kozlovski, et al.
Plos One|August 4, 2020
Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST)Amos Stemmer, Ran Shadmi, Orna Bregman-Amitai, et al.
Cancers|July 2, 2021
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung CancerAmir Onn, Teodor Gottfried, Amos Stemmer, et al.
Journal of Neuro-Oncology|January 12, 2022
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort studyAmir Massarweh, Roi Tschernichovsky, Amos Stemmer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patientsOfer Margalit, Amos Stemmer, William J Chapin, et al.
Journal of Clinical Medicine|May 14, 2022
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 YearsErez Bar-Haim, Noa Eliakim-Raz, Amos Stemmer, et al.
Pageof 2